+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
QLINE

Q-Line Biotech Share Price

 

 

Q-Line Biotech live price: ₹508.75. It opened at ₹510 vs previous close ₹515; intraday high/low: ₹529/₹495.

Q-Line Biotech Performance

  • Today's Low
  • ₹495
  • Today's High
  • ₹529
  • 52 Week Low
  • ₹431
  • 52 Week High
  • ₹529
  • Open Price₹510
  • Previous Close₹515
  • Volume155,600
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Q-Line Biotech Chart

Investment Returns

  • Over 1 Month + 48.32%
  • Over 3 Month + 48.32%
  • Over 6 Month + 48.32%
  • Over 1 Year + 48.32%

Smart Investing Starts Here Start SIP with Q-Line Biotech for Steady Growth!

Invest Now

Q-Line Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 42.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 1,187
  • P/B Ratio
  • 5
  • Average True Range
  • -
  • EPS
  • 19.33
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • -
  • MFI
  • -

Q-Line Biotech Financials

Q-Line Biotech Technicals

EMA & SMA

Current Price
₹508.75
-5.8 (-1.13%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 2
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

510.98 Pivot Speed
  • R3 560.27
  • R2 544.58
  • R1 526.67
  • S1 493.07
  • S2 477.38
  • S3 459.47

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

N/A

Group Rank

Q-Line Biotech Ltd develops, manufactures, and markets diagnostic reagents, kits, POC devices, consumables, and diagnostic equipment. Its products serve diagnostic laboratories, hospitals, and medical colleges. The company operates across Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and pathology equipment segments.

Q-Line Biotech Ltd has an operating revenue of Rs. 700.16 Cr. on a trailing 12-month basis. ROE of 21% is exceptional. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 6% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Group Rank of 165 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Q-Line Biotech Shareholding Pattern

No data available.

Q-Line Biotech FAQs

Q-Line Biotech share price is ₹508 As on 10 June, 2026 | 00:53

The Market Cap of Q-Line Biotech is ₹1186.8 Cr As on 10 June, 2026 | 00:53

The P/E ratio of Q-Line Biotech is 42.2 As on 10 June, 2026 | 00:53

The PB ratio of Q-Line Biotech is 5 As on 10 June, 2026 | 00:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23